share_log

NovAccess Global Inc. (OTCMKTS:XSNX) Short Interest Update

Financial News Live ·  Jul 17, 2022 02:40

NovAccess Global Inc. (OTCMKTS:XSNX – Get Rating) saw a large decrease in short interest in the month of June. As of June 30th, there was short interest totalling 6,000 shares, a decrease of 46.9% from the June 15th total of 11,300 shares. Based on an average trading volume of 4,000 shares, the short-interest ratio is currently 1.5 days.

NovAccess Global Stock Down 23.3 %

Shares of NovAccess Global stock opened at $0.15 on Friday. The company has a 50 day moving average of $0.24 and a 200-day moving average of $0.33. NovAccess Global has a 1-year low of $0.10 and a 1-year high of $0.96.

Get NovAccess Global alerts:

NovAccess Global Company Profile

(Get Rating)

NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc was incorporated in 1997 and is headquartered in Chesterland, Ohio.

Read More

  • Get a free copy of the StockNews.com research report on NovAccess Global (XSNX)
  • MarketBeat: Week in Review 7/11 – 7/15
  • Is Coupang's Stock On The Verge Of A Turnaround?
  • Should You Have These Two Banks In Your Portfolio?
  • Verint Systems Stock is a Customer Engagement Play
  • Why Shopify Stock Split...And is as Shoppable as Ever

Receive News & Ratings for NovAccess Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NovAccess Global and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment